Tissue Imaging/ Profiling; Prostate Cancer, Pancreatic Cancer, Breast Cancer, Cataracts, Arterial Stints, Polycystic Kidney Disease, Acute Kidney Disease, Cystic Fibrosis, & Liver Changes.

Prostasomes & Exosomes; Specific to Prostate and Breast Cancer by Quantitative iTRAQ LC-MS/MS.

Biomarker Discovery using Biological Fluids; from patients and animal models of; Pancreatic Cancer, Polycystic Kidney Disease, Prostate Cancer, Breast Cancer, Cervical Cancer, Dietary Studies.

Affects of Dietary Fatty Acids on Cancer Progression; Quantitative Global Proteomic Studies in Established Prostate Cancer Cell Lines.

Steroids as the Less Novel/ Novel Therapeutic; Studies in Established Prostate and Pancreatic Cell Lines using SILAC.

Reversing the FFPE Crosslink; Quantitative Proteomics on Fixed Tissues as compared to adjacent Flash Frozen Samples, collaboration with Qiagen and Protein Discovery.

Monitoring Degradation Products in Tissues; Programmed Proteolysis, and Oxidation, Relating to Post-Surgical Ischemia.

Informatics & Systems Biology; Sashimi Project & Cytoscape, from the front to back end, identification of the unseen by virtue of connecting the dots, collaboration with Institutes for System Biology (ISB).

Spectral Preprocessing & Statistical Analysis; Improving throughput and statistical strategies in the analysis of both MALDI MS profiles and of LCMS runs from biological fluids, cells in culture, and tissues. Collaborations with Genedata.

Finding a Cure Through Discovery Based Sciences

Research Focuses